Publication
Osteoporotic hip fractures: Bisphosphonates sales and observed turning point in trend. A population-based retrospective study
dc.contributor.author | Alves, Sandra Maria | |
dc.contributor.author | Economou, Theodoros | |
dc.contributor.author | Oliveira, Carla Maria | |
dc.contributor.author | Ribeiro, Ana Isabel | |
dc.contributor.author | Neves, Nuno | |
dc.contributor.author | Goméz-Barrena, Enrique | |
dc.contributor.author | Pina, Maria de Fátima | |
dc.date.accessioned | 2015-05-25T10:21:17Z | |
dc.date.available | 2015-05-25T10:21:17Z | |
dc.date.issued | 2013 | |
dc.description.abstract | The aim is to examine the temporal trends of hip fracture incidence in Portugal by sex and age groups, and explore the relation with anti-osteoporotic medication. From the National Hospital Discharge Database, we selected from 1st January 2000 to 31st December 2008, 77,083 hospital admissions (77.4% women) caused by osteoporotic hip fractures (low energy, patients over 49 years-age), with diagnosis codes 820.x of ICD 9-CM. The 2001 Portuguese population was used as standard to calculate direct age-standardized incidence rates (ASIR) (100,000 inhabitants). Generalized additive and linear models were used to evaluate and quantify temporal trends of age specific rates (AR), by sex. We identified 2003 as a turning point in the trend of ASIR of hip fractures in women. After 2003, the ASIR in women decreased on average by 10.3 cases/100,000 inhabitants, 95% CI (− 15.7 to − 4.8), per 100,000 anti-osteoporotic medication packages sold. For women aged 65–69 and 75–79 we identified the same turning point. However, for women aged over 80, the year 2004 marked a change in the trend, from an increase to a decrease. Among the population aged 70–74 a linear decrease of incidence rate (95% CI) was observed in both sexes, higher for women: − 28.0% (− 36.2 to − 19.5) change vs − 18.8%, (− 32.6 to − 2.3). The abrupt turning point in the trend of ASIR of hip fractures in women is compatible with an intervention, such as a medication. The trends were different according to gender and age group, but compatible with the pattern of bisphosphonates sales. | por |
dc.identifier.citation | Alves, S. M., Economou, T., Oliveira, C., Ribeiro, A. I., Neves, N., Goméz-Barrena, E., & Pina, M. F. (2013). Osteoporotic hip fractures: Bisphosphonates sales and observed turning point in trend. A population-based retrospective study. Bone, 53(2), 430–436. https://doi.org/10.1016/j.bone.2012.12.014 | |
dc.identifier.doi | 10.1016/j.bone.2012.12.014 | |
dc.identifier.uri | http://hdl.handle.net/10400.22/6087 | |
dc.language.iso | eng | por |
dc.peerreviewed | yes | por |
dc.publisher | Elsevier | por |
dc.relation.publisherversion | http://www.sciencedirect.com/science/article/pii/S8756328212014329 | por |
dc.subject | Bisphosphonates | por |
dc.subject | Osteoporosis | por |
dc.subject | Hip fractures | por |
dc.subject | Anti-osteoporotic medication | por |
dc.subject | Population studies | por |
dc.title | Osteoporotic hip fractures: Bisphosphonates sales and observed turning point in trend. A population-based retrospective study | por |
dc.type | journal article | |
dspace.entity.type | Publication | |
oaire.citation.endPage | 436 | por |
oaire.citation.startPage | 430 | por |
oaire.citation.title | BONE | por |
oaire.citation.volume | 53 | por |
person.familyName | Alves | |
person.familyName | Oliveira | |
person.givenName | Sandra Maria | |
person.givenName | Carla Maria | |
person.identifier | 2571691 | |
person.identifier.ciencia-id | CF1F-D1D5-6BC1 | |
person.identifier.ciencia-id | 291F-1C8B-BBC7 | |
person.identifier.orcid | 0000-0002-2318-7491 | |
person.identifier.orcid | 0000-0002-4594-1723 | |
rcaap.rights | openAccess | por |
rcaap.type | article | por |
relation.isAuthorOfPublication | f91e1151-4aad-4af3-9fef-970548be5f0c | |
relation.isAuthorOfPublication | a04f063b-e5de-4b9e-8979-62107b36b3b7 | |
relation.isAuthorOfPublication.latestForDiscovery | a04f063b-e5de-4b9e-8979-62107b36b3b7 |